A British court has ruled that nanoparticle applications developer Oxonica should pay licensing royalties to IP holding company Neuftec following an ongoing dispute lasting nearly two years. Though the initial formulation of...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)